Predictors of Favourable Response to Cardiac Resynchronization Therapy in Patients with Heart Failure with Reduced Ejection Fraction: A Narrative Review
Oct 2026· Biomedicines· Vol 14· 0 citations· 101 references
Medicine
Abstract
Cardiac resynchronization therapy (CRT) is an effective treatment for selected patients with heart failure with reduced ejection fraction, but 30–40% of recipients do not respond. This narrative review summarizes predictors of a favourable response to CRT. Typical left bundle branch block (LBBB) and a QRS duration ≥ 150 ms remain the best-established baseline predictors. Sex, etiology, age and comorbidities affect how much benefit is gained rather than acting as yes/no predictors (the benefit is greater in women, partly because of their smaller heart size) and should not by themselves exclude an otherwise eligible patient. QRS duration indexed to left ventricular size, advanced electrocardiographic markers (QRS notching, intrinsicoid deflection, QRmax, QRS area) and echocardiographic markers of mechanical dyssynchrony (apical rocking, septal flash, the classical LBBB strain pattern, systolic stretch index, mechanical dispersion and myocardial work) have been linked to response in observational studies and may add prognostic information. Combining mechanical dyssynchrony with septal viability on cardiac magnetic resonance appears to improve selection further. Procedure-related factors, including left ventricular lead position and a high percentage of biventricular pacing, are critical for success. A multimodal approach that combines clinical, electrocardiographic, echocardiographic and imaging data, supported in the future by machine learning, appears most promising.
BACKGROUND
Cardiac resynchronization therapy (CRT) improves survival and symptoms in patients with heart failure with reduced ejection fraction and electromechanical dyssynchrony, yet up to 30-40% do not respond despite guideline-based selection. Hemodynamic forces (HDF) quantify intraventricular pressure gradients and...
R. Tarantini, W. Gerrits, C. Chiu et al.· Journal of the American Soci...· 0 citations
Background: Cardiac resynchronization therapy (CRT) is an established treatment for heart failure with reduced ejection fraction (HFrEF) and electrical dyssynchrony, especially in patients with left bundle branch block (LBBB). In symptomatic patients with LVEF ≤35%, sinus rhythm and LBBB with a QRS duration ≥130 ms des...
F. Ramadhan, A. Rizal, Wella Karolina· Heart Science Journal· 0 citations
BACKGROUND
Sex-related differences in cardiac resynchronization therapy (CRT) outcomes in heart failure (HF) patients, particularly at shorter QRS durations, remain incompletely defined. We evaluated outcomes by sex and QRS duration in AdaptResponse trial and, pooled with Medtronic product surveillance registry (PSR) d...
T. Mela, W. Mullens, C. Leclercq et al.· Journal of Cardiac Failure· 0 citations
BACKGROUND AND AIMS
Up to 30% of patients fail to respond after cardiac resynchronization therapy (CRT). While echocardiographic predictors of response are well described in de novo CRT, evidence in CRT upgrade populations remains limited. We investigated predictors of echocardiographic response in the BUDAPEST-CRT Upg...
E. Merkel, R. Masszi, B. Lakatos et al.· Clinical Research in Cardiol...· 0 citations
Differences between ischemic and non-ischemic HFrEF referred for device implantation differ in LV remodeling and LA function, and the between-group differences were small in absolute terms, with widely overlapping distributions.
M. Dąbrowska, M. Potapowicz-Krysztofiak, M. Kiliszek et al.· Journal of Clinical Medicine· 0 citations
In this cohort, MWI dispersion showed the highest single-parameter discrimination for VAs among the echocardiographic variables tested, and its combination with RA area gave the best model.
M. Dąbrowska, M. Potapowicz-Krysztofiak, Patrycja Życzkowska et al.· Biomedicines· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.